Skip to main content
. 2026 Jun 15;19(6):941. doi: 10.3390/ph19060941
2-DG 2-deoxy-D-glucose
3-MA 3-methyladenine
ABCB1 ATP-binding cassette subfamily B member 1
AMPK Adenosine monophosphate-activated protein kinase
APL Acute promyelocytic leukemia
ASK1 Apoptosis signal-regulating kinase 1
ATF4 Activating transcription factor-4
ATF6 Activating transcription factor 6
ATO Arsenic trioxide
BiP Binding immunoglobulin protein
BTK inhibitors Bruton’s tyrosine kinase inhibitors
CHOP C/EBP homologous protein
COMET Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy
CuET Bis (diethyldithiocarbamate)-copper
DFS (−)-(2R, 3R)-1,4-O-diferuloylsecoisolariciresinol
DON Diazo-5-oxo-L-norleucine
DPAGT1 UDP-N-acetylglucosamine–dolichol phosphate N-acetylglucosamine-1-phosphate transferase
DR4 Death receptor 4
DR5 Death receptor 5
EDEM1 ER degradation-enhancing α-mannosidase-like protein 1
EGCG Epigallocatechin-3-gallate
eIF2α Eukaryotic translation initiation factor 2α
EMT Epithelial to mesenchymal transition
ER Endoplasmic reticulum
ERAD ER-associated degradation
FLCs Free light chains
GFAT Glutamine:fructose-6-phosphate amidotransferase
GRP78 Glucose-Regulated Protein 78
HDAC inhibitor Histone deacetylase inhibitor
HDAC6 Histone deacetylase 6
HNK Honokiol
Hsp70 Heat Shock Protein 70
HSP90 Heat Shock Protein 90
HSPA5 Heat Shock Protein Family A (Hsp70) Member 5 gene
IAP Inhibitor of Apoptosis
IRE1α Inositol-requiring enzyme 1 alpha
ISR Integrated Stress Response
JNK c-Jun N-terminal kinase
MCL Mantle cell lymphoma
MDR Multidrug-resistant
MFN2 Mitofusin 2
MiND Mitochondrial Network Disrupting Nanoparticles
MM Multiple myeloma
MTA Multitargeted antifolate
Nrf1/NFE2L1 Nuclear factor erythroid 2-related factor 1
OXPHOS Oxidative phosphorylation
PDI inhibitors Protein disulfide isomerase inhibitors
PDIA6 Protein disulphide isomerase-associated 6
PERK Protein kinase RNA-like endoplasmic reticulum kinase
P-gp P-glycoprotein
PI Proteasome inhibitor
PML Promyelocytic Leukemia protein
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RIDD Regulated IRE1α-dependent decay
ROS Reactive oxygen species
S2P Site-2-protease
SERCA sarcoplasmic/endoplasmic reticulum Ca2+-ATPase
TKI Tyrosine kinase inhibitor
TME Tumor microenvironment
TMZ Temozolomide
TNBC Triple Negative Breast Cancer
TRAF2 TNF receptor-associated factor 2
TRIB3 Tribbles 3
TRPV1 Transient Receptor Potential Vanilloid type 1
UPR Unfolded Protein Response
UPS Ubiquitin Proteasome System
XBP1 X-box binding protein 1
XN Xanthohumol